BIRC2 and neoplasm: Collectively, these findings suggest that BIRC2 knockdown in A549 and LLC‐1 cells results in decreased gene expression, inhibited proliferation, reduced clonogenic ability, and increased apoptosis, highlighting the critical role of BIRC2 in cell survival and tumour progression.